c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis
Wenfei Ji(Jiangsu Province Hospital), Xiaoxiang Guan(Nanjing General Hospital of Nanjing Military Command)
Cited by 90
Related Papers
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
|Cell Communication and Signaling|2023|165
Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
|Cellular Physiology and Biochemistry|2016|64
Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib
|International Journal of Biological Sciences|2019|30
Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer
|Acta Pharmaceutica Sinica B|2024|24